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Estrogen accelerates the development of renal disease in female obese
Zucker rats. Renal failure is the primary cause of death in obese Zucker
rats (OZR). We previously found that renal injury occurred earlier and
with greater severity in female OZR; also, prevention of hyperphagia
decreased renal damage in females more than males. To examine the
relationship between estrogen (E), hyperphagia, hyperlipidemia, and renal
injury in female OZR, we studied four groups from 5 to 10 or 21 weeks of
age: Sham-operated (Sham), ovariectomized (Ovx), Ovx with estrogen
treatment (Ovx1E), and, since Ovx increases food intake, Ovx pair-fed to
sham (Ovx-PF). By only six weeks of age, albumin excretion (UAE)
increased significantly in Ovx1E (9.9 6 4.1 mg/day). Ovx1E also ate least
and gained the least weight, but had the highest plasma lipid levels. In
contrast, UAE in Ovx did not increase by 10 weeks of age, despite a
significantly greater food consumption. The hyperlipidemia of Ovx1E was
due primarily to triglycerides. Both plasma triglycerides and renal injury,
judged from either histology or UAE, were greatest in the Ovx1E group.
Fasting plasma glucose was lower and insulin was higher in Ovx1E
compared to Ovx rats at 15 weeks of age. Estrogen may promote renal
injury in female OZR by increasing the plasma concentration of triglyc-
eride-rich lipoproteins.
The obese Zucker rat (OZR), a widely used model of obesity,
is hyperinsulinemic but not hyperglycemic up to one year of age
[1]. The OZR spontaneously develops renal failure characterized
by histopathologic changes similar to those found in patients with
NIDDM including mesangial matrix expansion and thickening of
the glomerular basement membrane [2]. At 9 to 13 weeks of age,
transglomerular capillary pressures in obese and lean male
Zucker rats do not differ [3]. Lipids are increased though, and
treatment with the lipid-lowering drugs clofibrate and mevolinin
markedly decrease glomerular damage [4]. These observations led
Keane and coworkers to propose that hyperlipidemia was impor-
tant in initiating renal injury in the OZR, but hemodynamics was
not involved [2, 3]. Additionally, macrophage infiltration and
hyperlipidemia occurs as early as four weeks of age in OZR [5].
Cholesterol has been the primary focus of the possible contribu-
tion of lipids to the development of renal disease. However, in
female OZR, proteinuria has been observed as early as seven
weeks of age, a period when only very-low density lipoprotein
(VLDL) is elevated [6].
Usually lipid levels are lower in female than in male rats [7].
Exceptions to this include the Nagase analbuminemic rat (NAR)
and rats with experimentally-induced nephrotic syndrome. Fe-
males in both have higher lipid levels [8, 9]. The hyperlipidemia in
these rats, due to hepatic overproduction, is corrected by ovari-
ectomy and exacerbated by estrogen administration [10]. Simi-
larly, some women given unopposed estrogens respond with
severe hyperlipidemia [11, 12], though on average, there is a small
but significant increase in plasma triglycerides [13].
In the OZR, we reported that renal failure occurs earlier in
females [14]. Lean Zucker rats also have a lower incidence of
end-stage renal disease at spontaneous death than do OZR.
When hyperphagia in OZR is prevented by pair-feeding to lean
littermates, renal disease is diminished in both sexes, but to a
greater degree in females than males [13, 15]. We conducted this
study in part to establish whether the gender differences in renal
disease seen in OZR are due to estrogen. Since estrogen has been
shown to increase triglycerides in female OZR [16], and lipids
have been implicated in the development of renal pathology in
OZR, we were interested in the role of lipids. These studies were
designed both to investigate the temporal relationship between
blood lipid levels and renal injury and to determine estrogen’s
influences on both.
METHODS
Experimental animals
Obese (fa/fa) female Zucker rats were obtained at four weeks of
age from the UC Davis NIH-funded Clinical Nutrition Research
Unit Animal Model Core. In study one, 31 rats were assigned to
one of four experimental groups while keeping initial body wts
equal: Sham (N 5 9), Ovx (N 5 7), Ovx1E (N 5 7) Ovx-PF (N 5
8). The Ovx-PF group was fed daily only the average amount
eaten by the sham group. This group was necessary because Ovx
causes increased food intake [17]. In study two, 18 obese female
Zucker rats were assigned to one of three groups: Sham (N 5 3),
Ovx (N 5 7), Ovx1E (N 5 8). For both groups, bilateral
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ovariectomy or sham surgery by dorsal approach and estrogen or
placebo treatment was performed at five weeks of age. Presence
or absence of ovaries was confirmed on termination. Rats in
studies one and two were terminated at 21 and 10 weeks of age,
respectively. An additional group of seven rats was terminated at
five weeks of age to provide baseline plasma lipid values.
Estrogen treatment
Rats in the Ovx1E groups were implanted with time release
pellets of 17b-estradiol, which release 0.0153 mg/day (Innovative
Research of America, Sarasota, FL, USA). The pellets used in
studies one and two were 90- and 60-day release, respectively.
Those in Sham groups were implanted with a placebo pellet. All
pellets were inserted subcutaneously via a small incision on the
nape of the neck. In study two, following kidney perfusion at
termination, uteri were removed, blotted dry, and weighed. Uter-
ine weights were used as an indicator of estrogen levels.
Diet, food intake and body weight
Rats were housed individually in stainless steel cages with wire
mesh floors and had free access to water and, except for Ovx-PF,
food. The light cycle was 0700 to 1900. All rats received a soy
protein-based (20%) refined diet that was previously found to
minimize renal injury in rats [18]. Body weights were measured
twice weekly for all rats. Food cups were replaced between 0800
and 1000 hours daily for the Ovx-PF group and twice weekly for
the other groups. Food intakes were measured at those times and
adjusted for spillage.
Urinary albumin excretion
Urine was taken over a 24-hour period by placing rats in
stainless steel metabolic cages and collecting the urine in flasks
containing three drops of 10% sodium azide solution to prevent
bacterial growth. Water was freely available, as was food moist-
ened with water to minimize spillage, except for the Ovx-PF group
which was given only their prescribed amount of food. Urinary
albumin excretion was determined using electroimmunodiffusion
using rabbit anti-rat albumin and purified rat albumin as previ-
ously described [19]. In study one, urine was collected at 21 weeks
for all groups, as well as at 8 and 10 weeks for Ovx, Sham, and
Ovx1E, and at six weeks for Ovx1E. In study two, urine was
collected weekly for all groups.
Plasma triglycerides and cholesterol
Prior to blood collection, all rats were fasted overnight. For
study one, in Ovx and Sham groups at 10 weeks of age, blood was
obtained by nicking the tail tip with a sterile scalpel and collected
in EDTA-coated capillary tubes. In all studies, including the
baseline rats, blood was taken by exsanguination at termination.
Rats were anesthetized with sodium pentobarbital and blood was
collected from the abdominal aorta in an EDTA-coated syringe.
Plasma was obtained by centrifugation, removed, and stored at
270°C until assayed. Measurements of plasma triglyceride and
cholesterol were made using enzymatic, colorimetric assays (Sig-
ma Chemical Co., St. Louis, MO, USA).
Insulin and glucose
In study one, fasted tail blood was collected again at 15 weeks.
Plasma glucose concentrations were determined using a YSI 2300
STAT plus glucose analyzer (Yellow Springs Instruments, Colum-
bus, OH, USA). Immunoreactive insulin was determined by
radioimmunoassay as previously described [20].
Renal histology
Histology was performed in study one. Following exsanguina-
tion under anesthesia, rats were infused via the abdominal aorta
with phosphate buffered saline (0.1 M PBS, pH 7.4) containing 6%
sucrose and 500 U heparin/liter for a sufficient time to blanch the
kidneys. A 0.05% glutaraldehyde/4% paraformaldehyde in PBS
fixative was then perfused for one minute or until the kidneys
became rigid. The fixative was removed by re-perfusion with the
PBS/sucrose/heparin solution. Tissue was then processed in glycol
methacrylate for light microscopy and immunohistochemistry as
described [21]. Sections were then stained by the periodic acid-
Schiff technique.
Glomeruli were scored by the method of Raij, Azar and Keane
as previously reported [22]. Thirty to 40 glomeruli were scored
from each kidney for three parameters: focal and segmental
glomerulosclerosis (FGS), mesangial matrix expansion (MME),
and visceral epithelial cell adhesion formation to Bowman’s
capsule (Adh). Each glomerulus was scored semiquantitatively on
a scale of 0 to 4 for each parameter depending on the percentage
of the glomerulus involved. A final score was obtained by multi-
plying the degree of change by the percent of glomeruli with the
degree of injury and adding scores. The maximum score obtain-
able for each rat was thus 400. Focal and segmental glomerulo-
sclerosis were scored positive when MME, adhesion formation
and capillary obliteration were present in the same segment of the
glomerulus.
Statistical analysis
Data were analyzed using Sigma Stat 2.0, a commercial statistics
program (Jandel, San Rafael, CA, USA). Data were first analyzed
for distribution. If the data were normally distributed, they were
analyzed for differences using one-way ANOVA. If differences
between the groups were detected, then a post hoc analysis was
performed using the Tukey test for multiple comparisons. If data
were not normally distributed, the significant differences between
median values were determined using Kruskal-Wallis one-way
ANOVA on ranks. If differences were detected, then multiple
comparisons were performed using Dunn’s method. Differences
were considered statistically significant at P # 0.05. Data are
presented as mean 6 standard error or median and range.
RESULTS
Food intake and body weight
Food intake and body wt in Ovx-PF and Sham groups did not
differ significantly (Table 1). Ovx rats ate significantly more and
were heavier than the other groups. In contrast, Ovx1E rats
weighed the least and had the lowest food intake throughout the
study. Food intake for Ovx1E was similar to that of the geneti-
cally lean (Fa/Fa) female Zucker rat [13]. Uterine mass per 100 g
body wt at 10 weeks was significantly lower in Ovx (Table 1).
Uterine weight in Ovx1E was slightly higher but not significantly
different than the sham animals, suggesting that the estrogen dose
was at least as much or slightly more than replacement levels.
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Urinary albumin excretion
At 21 weeks of age Ovx1E UAE was four- to sixfold higher
than the other groups (Fig. 1). Ovx1E UAE was significantly
higher than Ovx and Ovx-PF, but not Sham. In study two, Ovx1E
UAE was significantly higher than Ovx at all post-treatment time
points (Fig. 2). With the pooled data from studies one and two,
differences between Ovx1E and Ovx were significant by six
weeks. Compared to baseline UAE at five weeks (0.38 6 0.05
mg/day), Ovx1E and Sham increased significantly by 10 weeks
(114 6 28 and 20 6 10 mg/day), respectively, but Ovx did not
(1.6 6 0.9 mg/day). Remarkably, Ovx1E UAE was elevated only
one week after treatment (9.9 6 4.1 mg/day).
Plasma lipids
As with UAE, triglyceride levels at 21 weeks of age were highest
in Ovx1E (Fig. 3). Average triglycerides in Ovx1E were more
than twice as high as sham and 6 to 7 times higher than Ovx and
Ovx-PF. Despite the high variability in triglyceride values, differ-
ences between Ovx1E and both Ovx and Ovx-PF were highly
significant (P , 0.01). Cholesterol levels at 21 weeks in Ovx1E
were twice as high as the other groups, and this is the only group
that differed from the others (Fig. 3). The situation at 10 weeks of
age was much the same. Ovx1E triglycerides were much higher
than Ovx and Sham (Fig. 4), while Ovx1E had the highest
cholesterol levels, though differing significantly from Sham only
(Fig. 4).
Insulin and glucose
Insulin levels at 15 weeks were highest in Ovx1E, while glucose
was not elevated (Table 1). Ovariectomy led to increased blood
glucose, as Ovx was significantly higher than Sham and Ovx1E.
Histology
Histologic evaluation revealed significantly more FGS and
MME in Ovx1E than in any of the other three groups (Table 2
and Fig. 5), and significantly greater glomerular adhesion in
Ovx1E than in Ovx and Ovx-PF. The interstitium from Ovx-PF
animals was normal, while in the interstitium from the other three
groups, areas of tubular dilation were found.
Table 1. Body weight, total food intake, uterine mass, and fasted plasma insulin and glucose in female obese Zucker rats
Age
Body Wt
grams
20 weeks
Uterine mass
mg/100 g body weight
10 weeks
Total Food Intake
grams
5 to 20 weeks
Insulin
pm/liter
15 weeks
Glucose
mg/dl
15 weeks
Ovx-PF 450 6 5c — 1800 6 10c 1170 6 170b 154 6 4a,b
Ovx 537 6 15a 3.5 6 1.1a 2090 6 10a 1720 6 550b 165 6 9a
Ovx1E 266 6 7b 10.7 6 0.8b 1390 6 30b 6180 6 1310a 119 6 14b
Sham 434 6 3c 8.4 6 0.6b 1790 6 40c 1300 6 170b 130 6 5b
Abbreviations are: Ovx-PF, ovariectomized and pair-fed to Sham; Ovx, ovariectomized; Ovx1E, ovariectomized and estrogen treated; Sham, sham
operated. Values with different superscripts differ significantly (P , 0.05).
Fig. 1. Twenty-four-hour urinary albumin excretion (UAE) of female
obese Zucker rats at 21 weeks of age. Values are group average 6
standard error. Groups were compared to each other (ANOVA). Bars
with different letters differ significantly (P , 0.05). Abbreviations are:
Sham, Sham-operated control (N 5 9); Ovx1E, ovariectomized and
estrogen treated (N 5 7); Ovx, ovariectomized (N 5 7); Ovx-PF,
ovariectomized and pair-fed to Sham (N 5 8).
Fig. 2. Weekly 24-hour urinary albumin excretion (UAE) of female obese
Zucker rats from 5 to 10 weeks of age. Values are group average 6
standard error. Groups were compared to each other at the same time
point as well as the pooled five week average (ANOVA). Values with
different letters differ significantly (P , 0.05). Bars with an asterisk differ
significantly from the pooled five week average. Number per group is
indicated below each time point in the table. Symbols and abbreviations
are: (F) Sham, sham-operated control; (f) Ovx1E, ovariectomized and
estrogen treated; (L) Ovx, ovariectomized.
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DISCUSSION
The female OZR is infertile. It has delayed puberty, which does
not occur until eight or nine weeks of age [23, 24]. Infertility is
thought to be linked to abnormal estrous cycles, since estrogen
and gonadotropin levels are normal [25, 26]. Ovariectomy of OZR
has been previously reported to reduce plasma triglycerides, an
effect reversed by estrogen replacement [27]. The reduced estro-
gen level both decreased triglyceride production and increased
clearance [26]. Female OZR are not unique in this respect.
Estrogen massively increases triglyceride levels in the female
NAR and in female rats rendered nephrotic with adriamycin [28,
29]. The resultant hypertriglyceridemia initiates renal injury in the
normal remaining kidney of the uninephrectomized NAR and
exacerbates renal injury in the adriamycin model. In our model,
hyperlipidemia itself, principally hypertriglyceridemia, may play a
role in the initiation of renal injury since no alternative initiation
events have been identified.
While Ovx1E exhibited markedly increased hyperinsulinemia,
fasting insulin levels were the same in Ovx and Sham groups at 15
weeks. Thus, we find that in adult OZR, within which ovariectomy
does cause a decrease in estrogen [25], there is no evidence for the
direct dependence of insulin levels on estrogen. This increased
severity of NIDDM in Ovx1E may instead be a result of
hypertriglyceridemia. For example, while the fractional catabolic
rate of glucose is positively correlated with insulin in normal
humans, the same is not true of hypertriglyceridemics [29]. These
same individuals become more sensitive to insulin when their
hyperlipidemia is treated pharmacologically. Thus, estrogen’s
influence on insulin resistance here is likely indirect only, by
means of the amplified hypertriglyceridemia.
Hypercholesterolemia is an independent risk factor for the
development of renal disease in patients with diabetes [30, 31].
While this association has been made with respect to low density
lipoprotein (LDL) cholesterol, non-insulin-dependent diabetes
mellitus (NIDDM) is also characterized by increased lipoprotein
remnant particles [32, 33]. Clinical studies on patients with renal
disease, including NIDDM patients, and previous studies on the
OZR indicate that the hypertriglyceridemia observed is primarily
due to VLDL [6, 34, 35]. While VLDL may be metabolized to
either VLDL remnant particles or LDL, the low levels of LDL
that are seen in the rat [36] suggest that the primary pathway for
VLDL metabolism is through the generation of remnants, which
in turn are taken up by the liver. Very-low density lipoprotein has
not been directly shown to be either cytotoxic or to be taken up
directly by macrophages or mesangial cells. However, remnants
are atherogenic [37]. They are taken up by macrophages and are
toxic to them [38]. It is therefore possible that the hypertriglycer-
idemia induced by estrogen in the female OZR elevates circulat-
ing remnant particles, leading to glomerulosclerosis.
An interesting result is that the effects of estrogen outweigh the
effects of reduced food intake. Reduction of total caloric and/or
protein intake consistently protects against renal damage in rat
Fig. 3. Plasma triglycerides (M) and cholesterol (u) of female obese
Zucker rats at 21 weeks of age. Values are group average 6 standard
error. Groups were compared to each other by ANOVA. Bars with
different letters differ significantly (P , 0.05). Abbreviations are: Sham,
sham-operated control (N 5 9); Ovx1E. ovariectomized and estrogen
treated (N 5 7); Ovx, ovariectomized (N 5 7); Ovx-PF, ovariectomized
and pair-fed to Sham (N 5 8).
Fig. 4. Plasma triglycerides (M) and cholesterol (u) of female obese
Zucker rats at 10 weeks of age. Values are group average 6 standard
error. Groups were compared to each other as well as values from a five
weeks old control group (ANOVA). Bars with different letters differ
significantly (P , 0.05). Bars with an asterisk differ significantly (P , 0.05
from baseline) from the five week value of the control group (N 5 7).
Abbreviations are: Sham, sham-operated control (N 5 12); Ovx1E,
ovariectomized and estrogen treated (N 5 8); Ovx, ovariectomized (N 5
13); dotted line, baseline triglycerides; dashed line, cholesterol.
Table 2. Renal histopathology from obese female Zucker rats at 21
weeks of age
N
MME FGS Adhesions
Median Range Median Range Median Range
Sham 5 10a 3–33 0a 0–10 0a,b 0–15
Ovx1E 7 125b 38–235 3b 3–168 6b 3–168
Ovx 4 23a,b 10–33 0a 0–0 0a,b 0–8
Ovx-PF 6 9a 0–13 0a 0–0 0a 0–0
Abbreviations are: Sham, sham operated; Ovx1E, ovariectomized and
estrogen treated; Ovx, ovariectomized; Ovx-PF, ovariectomized and pair-
fed to Sham: MME, mesangial matrix expansion; FGS, focal and segmen-
tal glomerulosclerosis; Adhesions, visceral epithelial cell adhesions to
Bowman’s capsule. Values with different superscripts differ significantly
(P , 0.05).
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models, including the OZR [12, 13, 16]. Here, however, ovariec-
tomy was protective despite a 17% increase in food intake
compared to sham, while the 22% decrease seen in Ovx1E
resulted in greater damage. A likely explanation for this seeming
contradiction is that while reduced food intake has otherwise
salutary effects on plasma lipids, these effects can be overpowered
by the actions of estrogen [39].
We have now demonstrated that estrogen accelerates the
development of glomerular damage in the obese female Zucker
rat. Our observations that plasma lipids were significantly elevated
in Ovx1E compared to other groups, and that they had the most
severe level of histopathology and UAE support the hypothesis
that lipids play a role in initiation and/or progression of glomer-
ular injury [40]. Specifically, estrogen-induced VLDL elevations
may contribute to glomerular injury, causing proteinuria and
ultimately renal failure in the OZR. These findings have impor-
tant clinical implications for the large numbers of postmenopausal
women using hormone replacement therapy. We suggest that the
subset of these women who respond to estrogen with severely
elevated plasma triglycerides may be at risk for nephropathy as
well as atherosclerosis.
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